112372-15-3

Basic information

• Product Name: FURO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID
• Synonyms: FURO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID;2-Carboxyfuro[2,3-c]pyridine, 2-Carboxy-6-azabenzo[b]furan;Furo[2,3-c]pyridine-2-Carbocylic acid
• CAS NO: 112372-15-3
• Molecular Formula: C₈H₅NO₃
• Molecular Weight: 163.132
• Mol File: 112372-15-3.mol

Chemical Properties

• Melting Point: >320℃
• Boiling Point: 352.997 °C at 760 mmHg
• Flash Point: 167.287 °C
• Appearance: /
• Density: 1.455
• Storage Temp.: 2-8°C
• PKA: 1.95±0.30(Predicted)
• CAS DataBase Reference: FURO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: FURO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID(112372-15-3)
• EPA Substance Registry System: FURO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID(112372-15-3)

Safety Data

• Hazardous Substances Data: 112372-15-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
Furo[2,3-c]pyridine-2-carboxylic acid serves as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and functional groups contribute to its potential as a drug candidate for therapeutic uses, particularly in the development of anti-inflammatory and antimicrobial agents.
Used in Chemical Synthesis:
Furo[2,3-c]pyridine-2-carboxylic acid's distinctive molecular architecture positions it as a valuable target for chemical synthesis, where it can be further modified or used as a building block to create novel molecules with specific biological activities.
Used in Drug Development:
Furo[2,3-c]pyridine-2-carboxylic acid is utilized in drug development to explore its potential as a lead compound for new medications. Its pharmacological properties are under investigation for various applications, including the treatment of inflammatory conditions and infectious diseases.

Upstream product

• 106531-50-4 Ethyl 3-Hydroxyfuro<2,3-c>pyridine-2-carboxylate 
• 18343-02-7 Ethyl 2-(4-Ethoxycarbonyl-3-pyridyloxy) acetate 
• 18342-97-7 ethyl 3-hydroxyisonicotinate 
• 10128-71-9 3-hydroxyisonicotinic acid 
• 138173-83-8 Ethyl furo<2,3-c>pyridine-2-carboxylate 
• 927804-63-5 ethyl 3-(((trifluoromethyl) sulfonyl)oxy)furo[2,3-c]pyridine-2-carboxylate 
• 112372-06-2 furo<2,3-c>pyridine-2-carboxaldehyde 
• 112372-09-5 furo[2,3-c]pyridine-2-carbaldehyde oxime 
• 19539-50-5 furo<2,3-c>pyridine 
• 112372-12-0 2-cyanofuro<2,3-c>pyridine 

Downstream Products

• 1362160-47-1 sodium 4-((furo[2,3-c]pyridine-2-carboxamido)methyl)benzenesulfinate 
• 1362160-45-9 methyl 3-(4-((furo[2,3-c]pyridine-2-carboxamido)methyl)phenylsulfonyl)propanoate 
• 1362145-36-5 N-(4-((3-chloro-5-fluorophenyl)sulfonyl)benzyl)furo[2,3-c]pyridine-2-carboxamide 
• 465531-08-2 furo[2,3-c]pyridine-2-carbonyl chloride 
• 1453176-78-7 furo[2,3-c]pyridine-2-carboxylic acid benzylamide 
• 1453176-79-8 4-{[(furo[2,3-c]pyridine-2-carbonyl)-amino]-methyl}-benzenesulfonyl chloride 
• 1453173-84-6 N-[(4-tetrahydropyran-4-ylsulfonylphenyl)methyl]furo[2,3-c]pyridine-2-carboxamide 
• 1453174-07-6 N-[[4-[(1-tetrahydropyran-4-yl-4-piperidyl)sulfonyl]phenyl]methyl]furo[2,3-c]pyridine-2-carboxamide 
• 1453175-37-5 furo[2,3-c]pyridine-2-carboxylic acid 4-(1-isobutylpiperidine-4-sulfinyl)benzylamide 
• 1454250-73-7 furo[2,3-c]pyridine-2-carboxylic acid [5-(3,5-difluoro-benzenesulfonyl)-pyridin-2-ylmethyl]-amide 
• 1454255-03-8 N-[[5-(benzenesulfonyl)-2-pyridyl]methyl]furo[2,3-c]pyridin-2-carboxamide 
• 1454250-79-3 furo[2,3-c]pyridine-2-carboxylic acid (5-benzenesulfonyl-pyrimidin-2-ylmethyl)-amide 
• 1454285-17-6 N-[[4-(1-isopropylpyrazol-4-yl)sulfonylphenyl]methyl]furo[2,3-c]pyridine-2-carboxamide 
• 1362153-21-6 N-{[4-(benzenesulfonyl)phenyl]methyl}furo[2,3-c]pyridine-2-carboxamide 

Relevant articles and documents

AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

PYRIDINYL AND PYRIMIDINYL SULFOXIDE AND SULFONE DERIVATIVES

Disclosed are certain pyridinyl and pyrimidinyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds and methods of treatment using such compounds.

AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES

Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

AMIDO-BENZYL SULFONE AND SULFONAMIDE DERIVATIVES

Disclosed are certain amido-benzyl sulfone and sulfonamide compounds, pharmaceutical compositions comprising such compounds, land methods of treatment using such compounds.

AMIDO-BENZYL SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment of an NAMPT-mediated disease or condition in a subject, selected from solid or liquid tumor, rheumat

ALKYL-AND DI-SUBSTITUTED AMIDO-BENZYL SULFONAMIDE DERIVATIVES

The present invention relates to certain alkyl- and di-substituted amido-benzyl sulfonamide compounds, pharmaceutical compositions comprising such compounds, and to methods of treatment of NAMPT-mediated disorders, such as diabetes, rheumatoid arthritis,

NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT

The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below:

Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease

The invention provides compounds of Formula I: 1where in W is 2These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful to treat diseases or conditions in which α7 is known to be involved.

Furopyridines. VII. Preparation and Hydrolysis of 2-Cyano and 3-Cyano Derivatives of Furo-, Furo-, and Furopyridine

This paper describes the preparation and hydrolysis of 2-cyano and 3-cyano derivatives of furo-, furo-, and furopyridine.Treatment of furopyridines 1a, 1b and 1c with n-butyllithium in hexane-tetrahydrofuran at -70 deg C and subsequent addition of N,N-dimethylformamide yielded 2-formyl derivatives 2a, 2b and 2c.Dehydration of the oximes 4a, 4b and 4c of 2a, 2b and 2c gave 2-cyano compounds 5a, 5b and 5c, which were hydrolyzed to give 2-carboxylic acids, 6a, 6b and 6c, respectively.Reaction of 3-bromo compounds 7a, 7b and 7c with copper(I) cyanide in N,N-dimethylformamide afforded 3-cyano derivatives 8a, 8b and 8c.Alkaline hydrolysis of 8a, 8b and 8c gave compounds formed by fission of the 1-2 bond of furopyridines 9a, 9b and 9c, while acidic hydrolysis gave the corresponding carboxamides, 10a, 10b and 10c.